FDA Approved Products
4,491 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
COVERA-HS
verapamil hydrochloride
LOE Approaching
Pfizer
ORAL · TABLET, EXTENDED RELEASE
hypertensionto lower blood pressure+1
1996
NDA30/100
COZAAR
losartan potassium
LOE Approaching
Merck & Co.
ORAL · TABLET
hypertension in adultsolder+9
1995
NDA30/100
CRESTOR
rosuvastatin
LOE Approaching
AstraZeneca
ORAL · TABLET
2003
SMNDA30/100
CRINONE
progesterone
LOE Approaching
AbbVie
VAGINAL · GEL
secondary amenorrhea
1997
NDA30/100
CRINONE
progesterone
LOE Approaching
Teva
VAGINAL · GEL
secondary amenorrhea
1997
NDA30/100
CRIXIVAN
indinavir sulfate
LOE Approaching
Merck & Co.
ORAL · CAPSULE
HIV infection
1996
NDA30/100
CUPRIC CHLORIDE IN PLASTIC CONTAINER
cupric chloride
LOE Approaching
Pfizer
INJECTION · INJECTABLE
depletion of endogenous storessubsequent deficiency symptoms
1986
NDA30/100
CUPRIC SULFATE
cupric sulfate
LOE Approaching
Bristol Myers Squibb
INJECTION · INJECTABLE
1987
NDA30/100
CUPRIMINE
penicillamine
LOE Approaching
Bausch + Lomb
ORAL · CAPSULE
the treatment of Wilson's diseasecystinuria+6
1970
NDA30/100
CUTIVATE
fluticasone propionate
LOE Approaching
Sandoz
TOPICAL · LOTION
these symptoms of hay feverother upper respiratory allergies:
2005
NDA30/100
CUTIVATE
fluticasone propionate
LOE Approaching
Sandoz
TOPICAL · CREAM
these symptoms of hay feverother upper respiratory allergies:
1990
NDA30/100
CUTIVATE
fluticasone propionate
LOE Approaching
Sandoz
TOPICAL · OINTMENT
these symptoms of hay feverother upper respiratory allergies:
1990
NDA30/100
CUVPOSA
glycopyrrolate
LOE Approaching
Merz Therapeutics
ORAL · SOLUTION
chronic severe drooling in patients aged 3-16 years with neurologic conditions associated with problem drooling (e
2010
NDA30/100
CYANOCOBALAMIN
cyanocobalamin
LOE Approaching
AbbVie
INJECTION · INJECTABLE
anemia
1949
NDA30/100
CYANOKIT
hydroxocobalamin
LOE Approaching
INJECTION · INJECTABLE
knownsuspected cyanide poisoning
2006
NDA30/100
CYCLAPEN-W
cyclacillin
LOE Approaching
Thayer Medical
ORAL · TABLET
1979
NDA30/100
CYCLAPEN-W
cyclacillin
LOE Approaching
Thayer Medical
ORAL · FOR SUSPENSION
1979
NDA30/100
CYCLESSA
desogestrel; ethinyl estradiol
LOE Approaching
Aspen Surgical
ORAL-28 · TABLET
pregnancy in women
2000
NDA30/100
CYCLOCORT
amcinonide
LOE Approaching
Astellas
TOPICAL · LOTION
1988
NDA30/100
CYCLOCORT
amcinonide
LOE Approaching
Astellas
TOPICAL · OINTMENT
1981
NDA30/100
CYCLOCORT
amcinonide
LOE Approaching
Astellas
TOPICAL · CREAM
1979
NDA30/100
CYKLOKAPRON
tranexamic acid
LOE Approaching
Pfizer
ORAL · TABLET
hemophilia for short-term use (2 to 8 days) to reduceprevent hemorrhage+2
1986
NDA30/100
CYKLOKAPRON
tranexamic acid
LOE Approaching
Pfizer
INJECTION · INJECTABLE
hemophilia for short-term use (2 to 8 days) to reduceprevent hemorrhage+2
1986
NDA30/100
CYLERT
pemoline
LOE Approaching
Abbott
ORAL · TABLET, CHEWABLE
1976
NDA30/100